Clinical Trial RESULTS
60 mg 180 mg 360 mg 600 mg
Placebo AZD5718 AZD5718 AZD5718 AZD5718
Part B (Out of 8 (Out of 6 (Out of 6 (Out of 6 (Out of 6
(Liquid 1) participants) participants) participants) participants) participants)
How many
participants
4 participants 2 participants 3 participants 2 participants 3 participants
developed
(50.0%) (33.3%) (50.0%) (33.3%) (50.0%)
medical
problems?
How many participants developed serious medical problems?
A medical problem is considered serious when it is life-threatening, causes lasting
problems, or requires hospital care. No participants died in your study, and no
participants developed serious medical problems. No safety concerns were raised
during this study.
What were the most common medical problems?
The table below shows the medical problems that happened in at least 2 participants
in Part A, Group 1. All other medical problems happened in 1 participant.
25 mg 50 mg 100 mg 300 mg 600 mg 1200 mg
Part A Placebo AZD5718 AZD5718 AZD5718 AZD5718 AZD5718 AZD5718
Group 1 (Out of 12 (Out of 6 (Out of 6 (Out of 6 (Out of 6 (Out of 6 (Out of 6
(Liquid 1) participants) participants) participants) participants) participants) participants) participants)
0 participants 0 participants 0 participants 1 participant 0 participants 0 participants 2 participants
Headache
(0%) (0%) (0%) (16.7%) (0%) (0%) (33.3%)
In Part A, Group 2, no medical problem happened in more than 1 participant.
6